..., the challenge will continue as to the best way of optimizing its effect, and we can look forward to new developments in this expanding area of research. 13 2 2000 Erythropoietin Interleukin Folic acid Ascorbic acid 2000 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved...

...Neil Kurtzman; Sandra Sabatini Management of end-stage renal disease (ESRD) has been revolutionized by the advent of erythropoietin replacement. We briefly review its characteristics and clinical use. Also emphasized is the importance of iron deficiency in limiting the clinical response...